2006
Hyderabad
Late Stage
Sensa Core is an in‑vitro diagnostics (IVD) and medical device company that designs, manufactures, and supplies analytical and point‑of‑care diagnostic instruments, along with associated reagents and consumables, primarily for hospitals, pathology labs, and OEM/ODM clients in India and overseas.
Blood gas analyzers for arterial blood gas (ABG) and critical‑care testing, including hybrid systems that combine blood gas, electrolytes, and metabolites (glucose, lactate) in one analyzer for small and medium laboratories.
Electrolyte analyzers (Na, K, Cl, iCa, Li and related parameters) based on ion‑selective electrode (ISE) technology, supplied under Sensa Core’s own brand and as OEM modules for other brands.
Point‑of‑care devices such as glucose meters, hemoglobin meters, and lactate meters used in hospital, pathology, and veterinary settings.
Reagents, calibration packs, consumables, and ion‑selective electrodes specifically designed for Sensa Core analyzers and for OEM customers, enabling ongoing operation of installed instruments.
OEM/ODM services where Sensa Core designs and manufactures customized analyzers and embedded measurement modules for global healthcare companies to sell under their own brands.
Medical device manufacturing & sales model: Revenue from sales of capital equipment (blood gas analyzers, electrolyte analyzers, POCT devices) to hospitals, diagnostic labs, distributors, and international partners, typically via a mix of direct sales and channel distributors across multiple countries.
Razor‑razorblade consumables model: Recurring revenue from proprietary reagents, calibration solutions, cartridges, electrodes, and other consumables required for routine operation of installed analyzers, creating long‑term annuity‑like cash flows tied to test volumes.
OEM/ODM and technology licensing: Income from contract manufacturing and bespoke analyzer design for other medical device brands, where Sensa Core supplies analyzer platforms or ISE technology that power multiple third‑party electrolyte analyzers worldwide.
Service, maintenance, and AMC contracts: Additional revenue from installation, preventive maintenance, repairs, and aftermarket support for analyzers, often structured as annual maintenance contracts and extended warranties via its distributor and service network.
$72Million
1
$72Million, PE
as of December 22, 2025
-
as of N/A
-
as of N/A
Motilal Oswal
131
N/A
No Exits
| Date | Round Name | Amount | Valuation | Revenue | Revenue Multiple | Investors |
|---|---|---|---|---|---|---|
| December 22, 2025 | PE | $72Million | - | $47.8Million | - | Motilal Oswal |